DAMON CURTIS: Open Payments
NPI 1063895456 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 108 payments from 20 companies in 2025. Trend: 2023 $1,592 · 2024 $1,898 · 2025 $1,948
Food & beverage: $1,787Education: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $415 |
| Janssen Biotech, Inc. | 17 | $323 |
| Regeneron Healthcare Solutions, Inc. | 6 | $202 |
| LEO Pharma Inc. | 7 | $175 |
| Novartis Pharmaceuticals Corporation | 7 | $160 |
| Arcutis Biotherapeutics, Inc. | 5 | $144 |
| GENZYME CORPORATION | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| STRATA Skin Sciences, Inc. | 4 | $66 |
| Organon LLC | 3 | $49 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Zoryve, ADBRY, RINVOQ, COSENTYX, Sotyktu.
Industry payments across MA — which companies pay providers there.
